Equities

Aroa Biosurgery Ltd

Aroa Biosurgery Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)0.63
  • Today's Change0.00 / 0.00%
  • Shares traded106.13k
  • 1 Year change-10.00%
  • Beta1.1687
Data delayed at least 20 minutes, as of Nov 18 2024 04:56 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of NZD
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments304657
Total Receivables, Net292617
Total Inventory8.104.833.98
Prepaid expenses1.821.441.33
Other current assets, total00.190
Total current assets697880
Property, plant & equipment, net222115
Goodwill, net5.545.545.54
Intangibles, net141212
Long term investments------
Note receivable - long term------
Other long term assets------
Total assets111117113
LIABILITIES
Accounts payable1.711.911.33
Accrued expenses5.745.444.69
Notes payable/short-term debt000
Current portion long-term debt/capital leases1.000.560.59
Other current liabilities, total1.060.010.10
Total current liabilities9.517.916.71
Total long term debt6.436.555.29
Total debt7.447.115.88
Deferred income tax------
Minority interest------
Other liabilities, total0.170.170.16
Total liabilities161512
SHAREHOLDERS EQUITY
Common stock147146146
Additional paid-in capital------
Retained earnings (accumulated deficit)(52)(44)(46)
Treasury stock - common------
Unrealized gain (loss)0.701.261.24
Other equity, total(0.68)(1.52)(0.19)
Total equity95102100
Total liabilities & shareholders' equity111117113
Total common shares outstanding344343342
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.